In February 2021, a paper published in Cellular & Molecular Immunology confirmed that NSP12 suppresses the activity of a coding gene, IRF3 (interferon regulatory factor 3), key to the production of interferon.
Category: pharma & healthcare
Birth Of The Omicron Family: BA.1, BA.2, BA.3. Each As Different As Alpha Is From Delta.
Here, we introduce the Omicron family of variants. More detailed descriptions of each strain will follow this introduction. In this first entry, we will introduce the three, how they diverged from the Wuhan strain, and how they compare to each other.
New Clues To Long Covid: Prolonged Inflammatory Response
Long Covid patients show signs of sustained inflammation and immune response activation for at least 8 months after initial infection.
‘Why Did This Happen?’: Three Questions We Always Ask About Suicide
Suicide is still considered a shameful and grossly misunderstood act. Countless questions and emotions surround Regina King and so many others who experience suicide in their families.
The Danger Of Covid-19 Monotherapy: Drug Resistance
The current protocol for Omicron infections dictates that patients are treated with either one monoclonal antibody preparation or one antiviral drug. This is not an optimal strategy but instead, one necessitated by current drug approvals. Unfortunately…
Even Mild Covid-19 Can Cause Brain Dysfunction And Cognitive Issues
The research provides new clues as to why some people with long Covid experience long-term cognitive issues after being infected with the SARS-CoV-2 coronavirus.
Novel Antiviral Approach To Covid-19 Treatment
New antiviral drug, developed by Novartis and Molecular Partners, built to resist viral mutations and variants.
Novel Antiviral Approach To Covid-19 Treatment
New antiviral drug, developed by Novartis and Molecular Partners, built to resist viral mutations and variants.
Major Protease Of SARS-CoV-2 Acts To Suppress Innate Immunity
In October 2020, researchers discovered that the SARS-CoV-2 nonstructural protein 5 (NSP5) suppresses innate immunity. This has key implications for Covid-19 drug development that have yet to be fully explored.
Major Protease Of SARS-CoV-2 Acts To Suppress Innate Immunity
In October 2020, researchers discovered that the SARS-CoV-2 nonstructural protein 5 (NSP5) suppresses innate immunity. This has key implications for Covid-19 drug development that have yet to be fully explored.
